In this study, investigators designed a double-blind randomized trial to compare the efficacy and safety between sodium valproate, amisulpride and MECT combination therapy in clozapine-treated refractory schizophrenia (CTRS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Positive and Negative Syndrome Scale (PANSS)
Timeframe: the baseline
Positive and Negative Syndrome Scale (PANSS)
Timeframe: the end of the six week
Positive and Negative Syndrome Scale (PANSS)
Timeframe: the end of the twelve week
Scale for the Assessment of Negative Symptoms (SANS)
Timeframe: the baseline
Scale for the Assessment of Negative Symptoms (SANS)
Timeframe: the end of the six week
Scale for the Assessment of Negative Symptoms (SANS)
Timeframe: the end of the twelve week
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Timeframe: the baseline
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Timeframe: the end of the six week
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Timeframe: the end of the twelve week
Clinical Global Impression (CGI)
Timeframe: the baseline
Clinical Global Impression (CGI)
Timeframe: the end of the six week
Clinical Global Impression (CGI)
Timeframe: the end of the twelve week
Treatment Emergent Symptom Scale (TESS)
Timeframe: the baseline
Treatment Emergent Symptom Scale (TESS)
Timeframe: the end of the six week
Treatment Emergent Symptom Scale (TESS)
Timeframe: the end of the twelve week
plasma cytokines IL-2, IL-6 and TNF-α
Timeframe: the baseline
plasma cytokines IL-2, IL-6 and TNF-α
Timeframe: the end of the twelve week